However, TG101209 resulted in significant down regulation of LMO2 in K562 chronic myelogenous leukemia cell line (Supplemental Figure 2D) as reported previously [28]. This evidence concerns the gene LMO2 and chronic myelogenous leukemia, BCR-ABL1 positive.